Psilly - Solving America's Mental Health Crisis
For more information: https://invest.ei.ventures/
Ei.Venture in partnership with their portfolio company Psilly is hosting a webcast to help raise awareness of alternative approaches to treating mental health disorders like anxiety and depression. According to a study by John Hopkins Medicine, over 9.5% of adult Americans suffer from depression. Fortune Business Insights says that the global market size for anxiety disorders and depression treatment was USD $8.50 billion in 2019 and is projected to reach USD $13.03 billion by 2027. Additionally, over 18% of Americans suffer from anxiety disorders and up to 40% of Americans say they are more anxious in 2022 than last year. A good sign is that this number is down from 63% of those surveys since the spike up in 2021.
Why are modern day psychiatric drugs missing the market and how a group of entrepreneurs, researchers and scientists aim to fix it?
How ancient plant wisdom combined with 21st Century science is changing the way the world views psilocybin as a credible treatment plan?
Psilly will also cover their plans to build treatment centers in the Metaverse. Web 3.0 is a decentralized and fair internet where users control their own data, identity and destiny. Web 3.0 has enormous potential for growth over the next 25 years. The Psilly team has 144 lots of land in Sandbox that are in a prime location. In real estate, you have heard the term location, location, location. Well, the firm has digital real estate that is located right next door to the largest online play to earn decentralized video game company. The presentation will also include an overview of the Psilly thinking and plans. Having a view is great, having a view with an orthogonal expression is even better.
For more information: https://invest.ei.ventures/
- Future of Psychedelics and Mental Health
- Psychedelic Drugs Reduce Depressive Symptoms
- Sychedelics have the potential to open up new neural pathways
- Next generation psychedelic medicine
- Overview of Reg A Offerings
- How to invest in the golden age of psychedelics for as little as $498.
Event Recording
Psilly - Solving America's Mental Health Crisis
- Psilly - Solving Americas Mental Health CrisisPsilly PITCH DECK.pdf3 MB
Speakers
David Nikzad
- Title
- Chief Executive Officer @
- Company
- PSLY
- Role
- Speaker
David started his career in the techno scene, orchestrating parties that brought tens of thousands to hear internationally famous DJs at nightclubs such as Fifth Column, Trax, Buzz, Fever and others in DC.
Over the past 2.5 decades he has invested in real estate, nightlife, technology and wellness. He left the mainland over a decade ago to work on a retreat center in Maui called Lumeria, working there on his own emotional intelligence (E.I.) while continuing to invest in and guide startups.
PSYCHEDELICS, CLEAN FOOD, SPACE & STACKINGSATS.
Through his family venture fund Reinmkr Satsang and his holding company Orthogonal Thinker Inc., David put the first checks and some secondary checks into companies such as Betterment, Vidyard, InstantCab Ridecell, Wefunder, June Software TaptoLearn, Talkable, Aisle50, TutorSpree, OrangeFund2, Quartzy, Ridejoy, GazeHawk, RealCrowd, InvoiceASAP, Meadow, Mellows, ConfidentCannabis, FOBO Yardsale, BlockRx, SericaPay, Solti, AdStage, Arcview Capital, Airbnb, Republic, EquipmentShare, Stream, Supra Oracles, GARI, Skyryse, Firefly, AxiomSpace, IQ PROTOCOL, ETH, BTC, ZK.Link, Polygon, BANQ, Mycotopia, 1inch, DEALMAKER, MANA, CRO, CHINGARI, NEAR, Metaplex, MicroStrategy, Cannabis.NFT, RevenueRoll, SWAZIGOLD, goTenna, 12 x 12 SANDBOX LAND, Orthogonal Reg A Portal and many more.
We believe in something that ultimately is described as Utopian. A frequency that most won’t understand. Tapping into quantum physics and the idea of perpetual new frequencies within the interactions you have in your daily life. What we see touch feel and experience will determine the empowerment in your everyday life.
He has personally incubated companies through Orthogonal Thinker like SuryaSpa, KitchenNation, MauiRaw, Randy’s Remedy, E.I.Ventures, and Orthogonal Portal.
Over this last decade, David has become hyper-focused on his two children who live on Hawaii, and on his current role as Executive Chairman of Orthogonal Thinker Inc, which encompasses all of David’s family’s holdings.
His latest startup, Psilly, brought to you by E.I. Ventures, is focused on creating the new standard of mental wellness through developing novel psychedelic therapeutics, medicinal mushroom formulations, and unique treatment protocols and delivery mechanisms.
Cecil Robles
- Title
- CSO at E.I. Ventures
- Role
- Speaker
Cecil Robles is an entrepreneur executive and investor with 20 years of corporate brand building and strategic planning experience.
Throughout his career Cecil has helped grow brands to 8-figures and has been responsible for helping companies raise more than $100 million in capital.
Linda G Strause, PH.D.
- Title
- President @
- Company
- PSLY
- Role
- Speaker
Dr. Strause brings 30+ years of expertise in global clinical operations and clinical development, with an emphasis in oncology, critical care, and ethical considerations for subjects with life-threatening diseases, to the emerging market of psilocybin and psychedelics. Dr. Strause has held executive management positions at biotechnology companies, site management and healthcare research organizations, and at a global CRO. In addition she has been a Professor of Human Nutrition at the University of California, San Diego for over 30 years. In January 2022 Dr. Strause joined Ei.Ventures/Psilly as President. She is responsible for overseeing all clinical development programs with a specific focus on psychedelics. In addition, she has responsibilities to ensure that operations are conducted efficiently and effectively across all of Ei.Ventures/Psilly endeavors including, but not limited to, botanical health products, technology applications, and web3 performance. Ei (Emotional Intelligence) Ventures, is committed to the advancement of a safe, clean, and healthful world through the wisdom of plants.
Tyler Strause
- Title
- VP of Product/Product Development @
- Company
- PSLY
- Role
- Speaker
Tyler is responsible for product development, manufacturing, production, quality control, quality assurance, and customer satisfaction at Psilly and Ei Ventures. Tyler is also the Founder of G. Randall & Sons, Inc, where he created Randy's Remedy: a scientifically formulated topical cream optimized for the delivery of natural cannabinoids.
Tyler gained experience and knowledge of advanced botanical extraction and analytical techniques alongside Ph.D. analytical and physical chemists. He conducted extensive research about the antitumor effects of cannabinoids and became a subject matter expert. In 2012 Tyler founded Randy’s Club, a California non-profit serving the needs of qualified patients participating in the California State Medical Marijuana Program.
Tyler served as a board member of a local non-profit. He worked with local elected officials, patients, and community stakeholders to build a broad consensus around the principles of safe, affordable access to medical marijuana for qualified patients in San Diego and its surrounding communities. In addition, he was the manager at the first legally licensed dispensary in San Diego county, participating in start-up activities, ensuring compliance with regulations, and serving qualified customers.
Tyler also worked at UC Davis Cancer Center’s regulatory affairs office, San Diego Hospice Education and Research Department, and Aspire, an independent Institutional Review Board. He graduated with a degree in Philosophy from the University of California at Davis.
About
PSLY
More people than ever are struggling with mental health. As a society, we don’t currently have adequate mental health treatment that targets the root problem without hefty costs (reliance on daily medication, side effects, potential substance abuse). Big Pharma has failed to address the problem and the world wants a different solution.
Psilocybin and functional mushrooms allow us to rewire our neural pathways and naturally address what we typically try to control via medication. Psilly, brought to you by E.I. Ventures, is changing the narrative around psychedelic therapy so that plant-powered mushrooms can move through FDA trials and provide people a safer and more efficient path to self-improvement.
Psilly provides a path to what’s growing all around us: a “gold standard” of plant-powered, psychedelic therapy. Rather than compete over ownership of a natural compound, Psilly offers a delivery system, therapeutic framework, educational platform, and community that will ensure that people experience the value that psychedelic mushrooms have to offer for as accessible a cost as possible - $1 per dose.
We are focused on three key areas in order to scale psychedelic therapy and mental health and wellness options to the millions currently suffering:
1. Botanical pharmaceutical ingredients
2. Drug delivery mechanisms
3. Web3 psychedelic therapy and technology
Invest in Psilly, brought to you by E.I. Ventures, to bring 100% plant-based therapies through FDA trials to help 1 billion people for $1 each.
Learn more at invest.ei.ventures
We started our journey over 12 years ago in Los Angeles, bringing healing modalities to a growing community of individuals curious about alternative paths to health and wellness. Then came the island of Maui, Hawaii, where we connected with farmers, chemists, and iconic leaders of psychedelic medicine to explore the power of the plant and natural therapies that unlock the mind and heal the soul. Psilly, a continuation of Orthogonal Thinker and E.I. Ventures's mission of conscious, sustainable investing and community building, was born in 2021.
Our team consists of experts, teachers, and healers from across innovative corners of psychedelic medicine, cannabis, CBD, academia, and physical healing spaces. Working and living across Miami, Maui, and Northern California, we all share a common respect for natural medicine and what's possible when you reimagine the strategy of pharmaceuticals to present people with a new path to self-improvement.